Details for 2017187097
Up to date per 03.04.2026
Actions
Details for 2017187097
Deleted
European Patent
25.04.2018 A
24.03.2021 B1
12.07.2010
US
363610 P
31.03.2011
US
201161470412 P
01.04.2011
US
201161470812 P
A61K 31/675 20060101AFI20200929BHEP
Owner
Threshold Pharmaceuticals Inc.170 Harbor Way Suite 300 A 94080 San Francisco, CA 94080US
Representative
No representatives present
Inventor
KROLL, Stewartc/o Threshold Pharmaceuticals Inc. 170 Harbor Way, Suite 300 South San Francisco, CA 94080US
CURD, Johnc/o Threshold Pharmaceuticals Inc. 170 Harbor Way, Suite 300 South San Francisco, CA 94080US
HART, Charlesc/o Threshold Pharmaceuticals Inc. 170 Harbor Way, Suite 300 South San Francisco, CA 94080US
SUN, Jessicac/o Threshold Pharmaceuticals Inc. 170 Harbor Way, Suite 300 South San Francisco, CA 94080US